Impact of in-hospital discontinuation with angiotensin receptor blockers or converting enzyme inhibitors on mortality of COVID-19 patients: a retrospective cohort study

BACKGROUND: In the first wave of the COVID-19 pandemic, the hypothesis that angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) increased the risk and/or severity of the disease was widely spread. Consequently, in many hospitals, these drugs were discontinued as...

Descripción completa

Detalles Bibliográficos
Autores principales: de Abajo, Francisco J., Rodríguez-Miguel, Antonio, Rodríguez-Martín, Sara, Lerma, Victoria, García-Lledó, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114973/
https://www.ncbi.nlm.nih.gov/pubmed/33980231
http://dx.doi.org/10.1186/s12916-021-01992-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114973/
https://www.ncbi.nlm.nih.gov/pubmed/33980231
http://dx.doi.org/10.1186/s12916-021-01992-9

Ejemplares similares